Northern Oak Wealth Management Inc. boosted its position in Stryker Corporation (NYSE:SYK) by 38.1% during the first quarter, Holdings Channel reports. The fund owned 4,280 shares of the medical technology company’s stock after buying an additional 1,180 shares during the period. Northern Oak Wealth Management Inc.’s holdings in Stryker Corporation were worth $563,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of SYK. Bollard Group LLC increased its position in shares of Stryker Corporation by 0.4% in the first quarter. Bollard Group LLC now owns 829 shares of the medical technology company’s stock worth $109,000 after buying an additional 3 shares during the last quarter. Baystate Wealth Management LLC increased its position in shares of Stryker Corporation by 2.1% in the first quarter. Baystate Wealth Management LLC now owns 1,066 shares of the medical technology company’s stock worth $139,000 after buying an additional 22 shares during the last quarter. Guardian Life Insurance Co. of America increased its position in shares of Stryker Corporation by 0.8% in the first quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock worth $158,000 after buying an additional 9 shares during the last quarter. Assetmark Inc. increased its position in shares of Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock worth $168,000 after buying an additional 4 shares during the last quarter. Finally, Daiwa SB Investments Ltd. purchased a new position in shares of Stryker Corporation during the first quarter worth approximately $170,000. Hedge funds and other institutional investors own 73.99% of the company’s stock.

Shares of Stryker Corporation (NYSE:SYK) traded up 0.41% during midday trading on Friday, hitting $144.50. 262,217 shares of the stock were exchanged. Stryker Corporation has a 12-month low of $106.48 and a 12-month high of $148.84. The company has a market cap of $54.05 billion, a PE ratio of 32.25 and a beta of 0.80. The firm has a 50-day moving average price of $143.63 and a 200-day moving average price of $135.35.

Stryker Corporation (NYSE:SYK) last posted its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. The firm had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.98 billion. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. Stryker Corporation’s revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.39 EPS. On average, equities analysts predict that Stryker Corporation will post $6.50 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be issued a $0.425 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.18%. Stryker Corporation’s payout ratio is currently 37.95%.

ILLEGAL ACTIVITY WARNING: “Northern Oak Wealth Management Inc. Has $563,000 Stake in Stryker Corporation (SYK)” was first published by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/11/northern-oak-wealth-management-inc-has-563000-stake-in-stryker-corporation-syk.html.

A number of brokerages recently commented on SYK. Cowen and Company reiterated a “buy” rating and set a $160.00 target price (up previously from $150.00) on shares of Stryker Corporation in a research note on Sunday, July 30th. BidaskClub downgraded shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Zacks Investment Research upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating and set a $166.00 target price for the company in a research note on Tuesday, August 1st. Oppenheimer Holdings, Inc. set a $148.00 target price on shares of Stryker Corporation and gave the stock a “hold” rating in a research note on Friday, July 28th. Finally, Royal Bank Of Canada boosted their target price on shares of Stryker Corporation from $140.00 to $155.00 and gave the stock an “outperform” rating in a research note on Friday, July 28th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and twelve have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $144.03.

In other news, insider Graham A. Mclean sold 1,124 shares of Stryker Corporation stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total value of $164,396.24. Following the transaction, the insider now directly owns 8,983 shares of the company’s stock, valued at $1,313,853.58. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Lonny J. Carpenter sold 5,000 shares of Stryker Corporation stock in a transaction that occurred on Friday, August 4th. The stock was sold at an average price of $146.36, for a total transaction of $731,800.00. Following the completion of the transaction, the insider now directly owns 88,207 shares in the company, valued at $12,909,976.52. The disclosure for this sale can be found here. Insiders sold a total of 32,810 shares of company stock worth $4,754,958 over the last quarter. Insiders own 7.40% of the company’s stock.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.